Apresentação do PowerPoint - IMSN...Lisiane Leal, RPh, MSc PhD candidate in Epidemiology — UFRGS...
23
Transcript of Apresentação do PowerPoint - IMSN...Lisiane Leal, RPh, MSc PhD candidate in Epidemiology — UFRGS...
![Page 1: Apresentação do PowerPoint - IMSN...Lisiane Leal, RPh, MSc PhD candidate in Epidemiology — UFRGS Consultant, Institute for Safe Medication Practices — FDA/IMSN Global Summit](https://reader034.fdocuments.us/reader034/viewer/2022051605/6015d015d2ca8c2eee3bc638/html5/thumbnails/1.jpg)
![Page 2: Apresentação do PowerPoint - IMSN...Lisiane Leal, RPh, MSc PhD candidate in Epidemiology — UFRGS Consultant, Institute for Safe Medication Practices — FDA/IMSN Global Summit](https://reader034.fdocuments.us/reader034/viewer/2022051605/6015d015d2ca8c2eee3bc638/html5/thumbnails/2.jpg)
2
![Page 3: Apresentação do PowerPoint - IMSN...Lisiane Leal, RPh, MSc PhD candidate in Epidemiology — UFRGS Consultant, Institute for Safe Medication Practices — FDA/IMSN Global Summit](https://reader034.fdocuments.us/reader034/viewer/2022051605/6015d015d2ca8c2eee3bc638/html5/thumbnails/3.jpg)
![Page 4: Apresentação do PowerPoint - IMSN...Lisiane Leal, RPh, MSc PhD candidate in Epidemiology — UFRGS Consultant, Institute for Safe Medication Practices — FDA/IMSN Global Summit](https://reader034.fdocuments.us/reader034/viewer/2022051605/6015d015d2ca8c2eee3bc638/html5/thumbnails/4.jpg)
![Page 5: Apresentação do PowerPoint - IMSN...Lisiane Leal, RPh, MSc PhD candidate in Epidemiology — UFRGS Consultant, Institute for Safe Medication Practices — FDA/IMSN Global Summit](https://reader034.fdocuments.us/reader034/viewer/2022051605/6015d015d2ca8c2eee3bc638/html5/thumbnails/5.jpg)
![Page 6: Apresentação do PowerPoint - IMSN...Lisiane Leal, RPh, MSc PhD candidate in Epidemiology — UFRGS Consultant, Institute for Safe Medication Practices — FDA/IMSN Global Summit](https://reader034.fdocuments.us/reader034/viewer/2022051605/6015d015d2ca8c2eee3bc638/html5/thumbnails/6.jpg)
54.4%
![Page 7: Apresentação do PowerPoint - IMSN...Lisiane Leal, RPh, MSc PhD candidate in Epidemiology — UFRGS Consultant, Institute for Safe Medication Practices — FDA/IMSN Global Summit](https://reader034.fdocuments.us/reader034/viewer/2022051605/6015d015d2ca8c2eee3bc638/html5/thumbnails/7.jpg)
![Page 8: Apresentação do PowerPoint - IMSN...Lisiane Leal, RPh, MSc PhD candidate in Epidemiology — UFRGS Consultant, Institute for Safe Medication Practices — FDA/IMSN Global Summit](https://reader034.fdocuments.us/reader034/viewer/2022051605/6015d015d2ca8c2eee3bc638/html5/thumbnails/8.jpg)
• Amikacin 100mg/2ml• Amikacin 250mg/ml • Gentamicin 80mg/2ml
![Page 9: Apresentação do PowerPoint - IMSN...Lisiane Leal, RPh, MSc PhD candidate in Epidemiology — UFRGS Consultant, Institute for Safe Medication Practices — FDA/IMSN Global Summit](https://reader034.fdocuments.us/reader034/viewer/2022051605/6015d015d2ca8c2eee3bc638/html5/thumbnails/9.jpg)
• Metoclopramide• Lidocaíne• Amikacin 50mg/ml
• Amikacin 500mg/2 ml
![Page 10: Apresentação do PowerPoint - IMSN...Lisiane Leal, RPh, MSc PhD candidate in Epidemiology — UFRGS Consultant, Institute for Safe Medication Practices — FDA/IMSN Global Summit](https://reader034.fdocuments.us/reader034/viewer/2022051605/6015d015d2ca8c2eee3bc638/html5/thumbnails/10.jpg)
• Adrenaline• Phytonadione • Adrenaline
• Heparin
![Page 11: Apresentação do PowerPoint - IMSN...Lisiane Leal, RPh, MSc PhD candidate in Epidemiology — UFRGS Consultant, Institute for Safe Medication Practices — FDA/IMSN Global Summit](https://reader034.fdocuments.us/reader034/viewer/2022051605/6015d015d2ca8c2eee3bc638/html5/thumbnails/11.jpg)
• Complex B • Furosemide• Metamizol • Midazolam 5mg
• Midazolam 15mg
![Page 12: Apresentação do PowerPoint - IMSN...Lisiane Leal, RPh, MSc PhD candidate in Epidemiology — UFRGS Consultant, Institute for Safe Medication Practices — FDA/IMSN Global Summit](https://reader034.fdocuments.us/reader034/viewer/2022051605/6015d015d2ca8c2eee3bc638/html5/thumbnails/12.jpg)
• Metamizol• Ranitidine • Metamizol
• Salbutamol
![Page 13: Apresentação do PowerPoint - IMSN...Lisiane Leal, RPh, MSc PhD candidate in Epidemiology — UFRGS Consultant, Institute for Safe Medication Practices — FDA/IMSN Global Summit](https://reader034.fdocuments.us/reader034/viewer/2022051605/6015d015d2ca8c2eee3bc638/html5/thumbnails/13.jpg)
• Ondansetron• Norepinephrine
• Nitroglycerin• Dopamine
![Page 14: Apresentação do PowerPoint - IMSN...Lisiane Leal, RPh, MSc PhD candidate in Epidemiology — UFRGS Consultant, Institute for Safe Medication Practices — FDA/IMSN Global Summit](https://reader034.fdocuments.us/reader034/viewer/2022051605/6015d015d2ca8c2eee3bc638/html5/thumbnails/14.jpg)
![Page 15: Apresentação do PowerPoint - IMSN...Lisiane Leal, RPh, MSc PhD candidate in Epidemiology — UFRGS Consultant, Institute for Safe Medication Practices — FDA/IMSN Global Summit](https://reader034.fdocuments.us/reader034/viewer/2022051605/6015d015d2ca8c2eee3bc638/html5/thumbnails/15.jpg)
• Sodium chloride 0.9%• Sodium chloride 10%• Sodium chloride 20%
![Page 16: Apresentação do PowerPoint - IMSN...Lisiane Leal, RPh, MSc PhD candidate in Epidemiology — UFRGS Consultant, Institute for Safe Medication Practices — FDA/IMSN Global Summit](https://reader034.fdocuments.us/reader034/viewer/2022051605/6015d015d2ca8c2eee3bc638/html5/thumbnails/16.jpg)
![Page 17: Apresentação do PowerPoint - IMSN...Lisiane Leal, RPh, MSc PhD candidate in Epidemiology — UFRGS Consultant, Institute for Safe Medication Practices — FDA/IMSN Global Summit](https://reader034.fdocuments.us/reader034/viewer/2022051605/6015d015d2ca8c2eee3bc638/html5/thumbnails/17.jpg)
![Page 18: Apresentação do PowerPoint - IMSN...Lisiane Leal, RPh, MSc PhD candidate in Epidemiology — UFRGS Consultant, Institute for Safe Medication Practices — FDA/IMSN Global Summit](https://reader034.fdocuments.us/reader034/viewer/2022051605/6015d015d2ca8c2eee3bc638/html5/thumbnails/18.jpg)
![Page 19: Apresentação do PowerPoint - IMSN...Lisiane Leal, RPh, MSc PhD candidate in Epidemiology — UFRGS Consultant, Institute for Safe Medication Practices — FDA/IMSN Global Summit](https://reader034.fdocuments.us/reader034/viewer/2022051605/6015d015d2ca8c2eee3bc638/html5/thumbnails/19.jpg)
![Page 20: Apresentação do PowerPoint - IMSN...Lisiane Leal, RPh, MSc PhD candidate in Epidemiology — UFRGS Consultant, Institute for Safe Medication Practices — FDA/IMSN Global Summit](https://reader034.fdocuments.us/reader034/viewer/2022051605/6015d015d2ca8c2eee3bc638/html5/thumbnails/20.jpg)
20
![Page 21: Apresentação do PowerPoint - IMSN...Lisiane Leal, RPh, MSc PhD candidate in Epidemiology — UFRGS Consultant, Institute for Safe Medication Practices — FDA/IMSN Global Summit](https://reader034.fdocuments.us/reader034/viewer/2022051605/6015d015d2ca8c2eee3bc638/html5/thumbnails/21.jpg)
![Page 22: Apresentação do PowerPoint - IMSN...Lisiane Leal, RPh, MSc PhD candidate in Epidemiology — UFRGS Consultant, Institute for Safe Medication Practices — FDA/IMSN Global Summit](https://reader034.fdocuments.us/reader034/viewer/2022051605/6015d015d2ca8c2eee3bc638/html5/thumbnails/22.jpg)
![Page 23: Apresentação do PowerPoint - IMSN...Lisiane Leal, RPh, MSc PhD candidate in Epidemiology — UFRGS Consultant, Institute for Safe Medication Practices — FDA/IMSN Global Summit](https://reader034.fdocuments.us/reader034/viewer/2022051605/6015d015d2ca8c2eee3bc638/html5/thumbnails/23.jpg)